These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 31009895)
1. Pretreatment with resveratrol ameliorate trigeminal neuralgia by suppressing matrix metalloproteinase-9/2 in trigeminal ganglion. Yin Y; Guo R; Shao Y; Ge M; Miao C; Cao L; Yang Y; Hu L Int Immunopharmacol; 2019 Jul; 72():339-347. PubMed ID: 31009895 [TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of tetramethylpyrazine on pain transmission of trigeminal neuralgia in CCI-ION rats. Xiong W; Tan M; He L; Ou X; Jin Y; Yang G; Huang L; Shen Y; Guan S; Xu C; Li G; Liu S; Xu H; Liang S; Gao Y Brain Res Bull; 2017 Sep; 134():72-78. PubMed ID: 28710025 [TBL] [Abstract][Full Text] [Related]
3. Resveratrol suppresses glial activation and alleviates trigeminal neuralgia via activation of AMPK. Yang YJ; Hu L; Xia YP; Jiang CY; Miao C; Yang CQ; Yuan M; Wang L J Neuroinflammation; 2016 Apr; 13(1):84. PubMed ID: 27093858 [TBL] [Abstract][Full Text] [Related]
4. Involvement of the BNP/NPR-A/BKCa pathway in rat trigeminal ganglia following chronic constriction injury. Xu W; Yao Y; Zhu D; Han L; Wang L; Wang Y J Neurophysiol; 2021 Apr; 125(4):1139-1145. PubMed ID: 33596737 [TBL] [Abstract][Full Text] [Related]
5. Unilateral facial injection of Botulinum neurotoxin A attenuates bilateral trigeminal neuropathic pain and anxiety-like behaviors through inhibition of TLR2-mediated neuroinflammation in mice. Chen WJ; Niu JQ; Chen YT; Deng WJ; Xu YY; Liu J; Luo WF; Liu T J Headache Pain; 2021 May; 22(1):38. PubMed ID: 34000998 [TBL] [Abstract][Full Text] [Related]
6. The CSF1-CSF1R pathway in the trigeminal ganglion mediates trigeminal neuralgia via inflammatory responses in mice. He Z; Xu C; Guo J; Liu T; Zhang Y; Feng Y Mol Biol Rep; 2024 Jan; 51(1):215. PubMed ID: 38281257 [TBL] [Abstract][Full Text] [Related]
7. Chemogenetic inhibition of trigeminal ganglion neurons attenuates behavioural and neural pain responses in a model of trigeminal neuropathic pain. Korczeniewska OA; James MH; Eliav T; Katzmann Rider G; Mehr JB; Affendi H; Aston-Jones G; Benoliel R Eur J Pain; 2022 Mar; 26(3):634-647. PubMed ID: 34767278 [TBL] [Abstract][Full Text] [Related]
8. Procyanidins attenuate neuropathic pain by suppressing matrix metalloproteinase-9/2. Pan C; Wang C; Zhang L; Song L; Chen Y; Liu B; Liu WT; Hu L; Pan Y J Neuroinflammation; 2018 Jun; 15(1):187. PubMed ID: 29929563 [TBL] [Abstract][Full Text] [Related]
10. Resveratrol attenuates neuropathic pain through balancing pro-inflammatory and anti-inflammatory cytokines release in mice. Tao L; Ding Q; Gao C; Sun X Int Immunopharmacol; 2016 May; 34():165-172. PubMed ID: 26953646 [TBL] [Abstract][Full Text] [Related]
11. Botulinum toxin type A reduces the expression of transient receptor potential melastatin 3 and transient receptor potential vanilloid type 4 in the trigeminal subnucleus caudalis of a rat model of trigeminal neuralgia. Zhang Y; Su Q; Lian Y; Chen Y Neuroreport; 2019 Jul; 30(10):735-740. PubMed ID: 31116130 [TBL] [Abstract][Full Text] [Related]
12. P2Y Lin J; Fang X; Liu F; Zhang Y; Li Y; Fang Z; Tang Q; Li C; Zhou C; Shen J Eur J Pharmacol; 2022 Sep; 931():175211. PubMed ID: 35981606 [TBL] [Abstract][Full Text] [Related]
13. Implication of the chemokine CCL2 in trigeminal nociception and traumatic neuropathic orofacial pain. Dauvergne C; Molet J; Reaux-Le Goazigo A; Mauborgne A; Mélik-Parsadaniantz S; Boucher Y; Pohl M Eur J Pain; 2014 Mar; 18(3):360-75. PubMed ID: 23918315 [TBL] [Abstract][Full Text] [Related]
14. Chemokine CXCL13 mediates orofacial neuropathic pain via CXCR5/ERK pathway in the trigeminal ganglion of mice. Zhang Q; Cao DL; Zhang ZJ; Jiang BC; Gao YJ J Neuroinflammation; 2016 Jul; 13(1):183. PubMed ID: 27401148 [TBL] [Abstract][Full Text] [Related]
15. TLR8 in the Trigeminal Ganglion Contributes to the Maintenance of Trigeminal Neuropathic Pain in Mice. Zhao LX; Jiang M; Bai XQ; Cao DL; Wu XB; Zhang J; Guo JS; Chen TT; Wang J; Wu H; Gao YJ; Zhang ZJ Neurosci Bull; 2021 Apr; 37(4):550-562. PubMed ID: 33355900 [TBL] [Abstract][Full Text] [Related]
16. The glial-neuronal GRK2 pathway participates in the development of trigeminal neuropathic pain in rats. Won KA; Kim MJ; Yang KY; Park JS; Lee MK; Park MK; Bae YC; Ahn DK J Pain; 2014 Mar; 15(3):250-61. PubMed ID: 24216329 [TBL] [Abstract][Full Text] [Related]
17. Tizanidine exerts anti-nociceptive effects in spared nerve injury model of neuropathic pain through inhibition of TLR4/NF-κB pathway. Pei W; Zou Y; Wang W; Wei L; Zhao Y; Li L Int J Mol Med; 2018 Dec; 42(6):3209-3219. PubMed ID: 30221670 [TBL] [Abstract][Full Text] [Related]
18. Urotensin II inhibitor eases neuropathic pain by suppressing the JNK/NF-κB pathway. Li J; Zhao PP; Hao T; Wang D; Wang Y; Zhu YZ; Wu YQ; Zhou CH J Endocrinol; 2017 Feb; 232(2):165-174. PubMed ID: 27895138 [TBL] [Abstract][Full Text] [Related]
19. Involvement of GABAergic, glutamatergic, opioidergic, and brain-derived neurotrophic factor systems in the trigeminal neuropathic pain process. Finamor F; Scarabelot VL; Medeiros LF; Stein DJ; da Silva MD; Callai E; Caumo W; de Souza A; Torres ILS Neurosci Lett; 2023 Jan; 793():136970. PubMed ID: 36402255 [TBL] [Abstract][Full Text] [Related]
20. Effects of intrathecal epigallocatechin gallate, an inhibitor of Toll-like receptor 4, on chronic neuropathic pain in rats. Kuang X; Huang Y; Gu HF; Zu XY; Zou WY; Song ZB; Guo QL Eur J Pharmacol; 2012 Feb; 676(1-3):51-6. PubMed ID: 22173123 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]